Top Pharmaceuticals companies in United States by EBT Margin

This ranking features the top 621 Pharmaceuticals companies in United States ranked by EBT Margin, averaging a EBT Margin of -3,206,762.92%, for January 15, 2025.

United States

Pharmaceuticals

#	Name	EBT Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,778.84%	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Agios Pharmaceuticals, Inc. 2 AGIO	2,212.98%	Sept. 30, 2024	USD 33.32	-2.86%	United States
3	Eledon Pharmaceuticals, Inc. 3 ELDN	2,168.39%	Sept. 30, 2024	USD 3.71	-4.63%	United States
4	Oramed Pharmaceuticals Inc. 4 ORMP	1,518.25%	March 31, 2024	USD 2.36	NA	United States
5	Maravai LifeSciences Holdings, Inc. 5 MRVI	159.33%	Sept. 30, 2024	USD 4.54	-7.91%	United States
6	Royalty Pharma plc 6 RPRX	75.66%	Sept. 30, 2024	USD 30.03	0.13%	United States
7	SIGA Technologies, Inc. 7 SIGA	63.52%	Sept. 30, 2024	USD 6.33	4.46%	United States
8	Protagonist Therapeutics, Inc. 8 PTGX	53.45%	Sept. 30, 2024	USD 36.67	-1.26%	United States
9	United Therapeutics Corporation 9 UTHR	52.17%	Sept. 30, 2024	USD 364.70	0.50%	United States
10	Halozyme Therapeutics, Inc. 10 HALO	50.68%	Sept. 30, 2024	USD 53.83	-0.57%	United States
11	Utah Medical Products, Inc. 11 UTMD	41.30%	Sept. 30, 2024	USD 61.49	0.77%	United States
12	Catalyst Pharmaceuticals, Inc. 12 CPRX	41.00%	Sept. 30, 2024	USD 22.19	-0.09%	United States
13	Ligand Pharmaceuticals Incorporated 13 LGND	38.59%	Sept. 30, 2024	USD 108.55	2.54%	United States
14	Lantheus Holdings, Inc. 14 LNTH	38.09%	Sept. 30, 2024	USD 92.62	-2.15%	United States
15	Regeneron Pharmaceuticals, Inc. 15 REGN	35.89%	Sept. 30, 2024	USD 690.87	-3.63%	United States
16	United-Guardian, Inc. 16 UG	35.73%	Sept. 30, 2024	USD 10.50	-0.19%	United States
17	Entrada Therapeutics, Inc. 17 TRDA	35.51%	Sept. 30, 2024	USD 12.49	-6.58%	United States
18	Kiora Pharmaceuticals, Inc. 18 KPRX	34.59%	Sept. 30, 2024	USD 3.21	-5.87%	United States
19	Zoetis Inc. 19 ZTS	33.34%	Sept. 30, 2024	USD 164.41	-1.15%	United States
20	IRadimed Corporation 20 IRMD	33.12%	Sept. 30, 2024	USD 57.52	1.79%	United States
21	Sensus Healthcare, Inc. 21 SRTS	31.16%	Sept. 30, 2024	USD 6.64	4.08%	United States
22	Semler Scientific, Inc. 22 SMLR	30.75%	Sept. 30, 2024	USD 54.93	4.23%	United States
23	Intuitive Surgical, Inc. 23 ISRG	30.25%	Sept. 30, 2024	USD 538.88	-0.16%	United States
24	SWK Holdings Corporation 24 SWKH	30.11%	Sept. 30, 2024	USD 16.15	-0.92%	United States
25	Exelixis, Inc. 25 EXEL	28.82%	Sept. 27, 2024	USD 35.65	0.99%	United States
26	ResMed Inc. 26 RMD	28.62%	Sept. 30, 2024	USD 228.83	-0.62%	United States
27	IDEXX Laboratories, Inc. 27 IDXX	28.43%	Sept. 30, 2024	USD 418.63	-0.94%	United States
28	Edwards Lifesciences Corporation 28 EW	27.59%	Sept. 30, 2024	USD 71.04	-0.07%	United States
29	MEI Pharma, Inc. 29 MEIP	27.23%	June 30, 2024	USD 2.75	1.10%	United States
30	Corcept Therapeutics Incorporated 30 CORT	26.46%	Sept. 30, 2024	USD 51.66	1.18%	United States
31	Amphastar Pharmaceuticals, Inc. 31 AMPH	25.95%	Sept. 30, 2024	USD 38.48	1.48%	United States
32	Harmony Biosciences Holdings, Inc. 32 HRMY	25.71%	Sept. 30, 2024	USD 36.42	-0.08%	United States
33	LeMaitre Vascular, Inc. 33 LMAT	25.43%	Sept. 30, 2024	USD 95.85	1.78%	United States
34	Eli Lilly and Company 34 LLY	24.84%	Sept. 30, 2024	USD 744.91	-6.59%	United States
35	Waters Corporation 35 WAT	24.63%	Sept. 28, 2024	USD 404.93	1.26%	United States
36	Tenet Healthcare Corporation 36 THC	24.38%	Sept. 30, 2024	USD 127.63	-1.27%	United States
37	Prestige Consumer Healthcare Inc. 37 PBH	24.04%	Sept. 30, 2024	USD 75.78	1.54%	United States
38	Krystal Biotech, Inc. 38 KRYS	23.77%	Sept. 30, 2024	USD 142.64	-5.10%	United States
39	Agilent Technologies, Inc. 39 A	23.36%	Oct. 31, 2024	USD 143.43	1.04%	United States
40	Neurocrine Biosciences, Inc. 40 NBIX	23.26%	Sept. 30, 2024	USD 139.51	-2.46%	United States
41	Merck & Co., Inc. 41 MRK	21.70%	Sept. 30, 2024	USD 99.65	-1.32%	United States
42	Hologic, Inc. 42 HOLX	21.47%	Sept. 28, 2024	USD 70.20	-0.13%	United States
43	Collegium Pharmaceutical, Inc. 43 COLL	21.36%	Sept. 30, 2024	USD 33.18	-1.80%	United States
44	Medpace Holdings, Inc. 44 MEDP	20.90%	Sept. 30, 2024	USD 330.91	-5.99%	United States
45	MiMedx Group, Inc. 45 MDXG	20.82%	Sept. 30, 2024	USD 8.61	0.58%	United States
46	West Pharmaceutical Services, Inc. 46 WST	20.47%	Sept. 30, 2024	USD 328.96	-3.13%	United States
47	Innoviva, Inc. 47 INVA	20.35%	Sept. 30, 2024	USD 17.68	0.68%	United States
48	Biogen Inc. 48 BIIB	20.27%	Sept. 30, 2024	USD 143.06	-4.74%	United States
49	Johnson & Johnson 49 JNJ	20.10%	Sept. 29, 2024	USD 144.75	0.19%	United States
50	Colgate-Palmolive Company 50 CL	19.65%	Sept. 30, 2024	USD 87.67	0.65%	United States

1 2 3 4 … 13

Frequently Asked Questions

Which Pharmaceuticals company in United States has the highest EBT Margin ?

The Pharmaceuticals company in United States with the highest EBT Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,778.84%.
Which Pharmaceuticals company in United States has the lowest EBT Margin ?

The Pharmaceuticals company in United States with the lowest EBT Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Pharmaceuticals companies in United States by EBT Margin ?

The top 10 Pharmaceuticals companies in United States by EBT Margin are Inhibrx Biosciences, Inc., Agios Pharmaceuticals, Inc., Eledon Pharmaceuticals, Inc., Oramed Pharmaceuticals Inc., Maravai LifeSciences Holdings, Inc., Royalty Pharma plc, SIGA Technologies, Inc., Protagonist Therapeutics, Inc., United Therapeutics Corporation and Halozyme Therapeutics, Inc..
What are the bottom 10 Pharmaceuticals companies in United States by EBT Margin ?

The bottom 10 Pharmaceuticals companies in United States by EBT Margin are Inhibikase Therapeutics, Inc., ZyVersa Therapeutics, Inc., Inovio Pharmaceuticals, Inc., Allogene Therapeutics, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Cadrenal Therapeutics, Inc. Common Stock and NRx Pharmaceuticals, Inc..